Braidwell-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
64
Total Value
2844802567
Accession Number
0001420506-25-001293
Form Type
13F-HR
Manager Name
Braidwell-Lp
Data Enrichment
75% identified
48 identified16 unidentified

Holdings

64 positions • $2.8B total value
Manager:
Search and click to pin securities to the top
Page 3 of 4
252131AM9
Shares:
Value:$22.8M
% of Portfolio:0.8% ($22.8M/$2.8B)
MARAVAI LIFESCIENCES HOLDINGS, INC.
Shares:8.4M
Value:$18.5M
% of Portfolio:0.6% ($18.5M/$2.8B)
252131AK3
Shares:
Value:$18.0M
% of Portfolio:0.6% ($18.0M/$2.8B)
Xencor Inc
Shares:1.7M
Value:$17.6M
% of Portfolio:0.6% ($17.6M/$2.8B)
Ascendis Pharma A/S
Shares:106.7K
Value:$16.6M
% of Portfolio:0.6% ($16.6M/$2.8B)
Oruka Therapeutics, Inc.
Shares:1.6M
Value:$16.1M
% of Portfolio:0.6% ($16.1M/$2.8B)
MADRIGAL PHARMACEUTICALS, INC.
Shares:48.7K
Value:$16.1M
% of Portfolio:0.6% ($16.1M/$2.8B)
Sarepta Therapeutics, Inc.
Shares:234.5K
Value:$15.0M
% of Portfolio:0.5% ($15.0M/$2.8B)
Replimune Group, Inc.
Shares:1.5M
Value:$14.3M
% of Portfolio:0.5% ($14.3M/$2.8B)
REPLIGEN CORP
Shares:81.7K
Value:$10.4M
% of Portfolio:0.4% ($10.4M/$2.8B)
IRONWOOD PHARMACEUTICALS INC
Shares:6.6M
Value:$9.7M
% of Portfolio:0.3% ($9.7M/$2.8B)
Celcuity Inc.
Shares:884.3K
Value:$8.9M
% of Portfolio:0.3% ($8.9M/$2.8B)
Cullinan Therapeutics, Inc.
Shares:980.8K
Value:$7.4M
% of Portfolio:0.3% ($7.4M/$2.8B)
CASTLE BIOSCIENCES INC
Shares:365.2K
Value:$7.3M
% of Portfolio:0.3% ($7.3M/$2.8B)
Dianthus Therapeutics, Inc. /DE/
Shares:375.4K
Value:$6.8M
% of Portfolio:0.2% ($6.8M/$2.8B)
02081GAB8
Shares:
Value:$5.8M
% of Portfolio:0.2% ($5.8M/$2.8B)
Pulmonx Corp
Shares:752.5K
Value:$5.1M
% of Portfolio:0.2% ($5.1M/$2.8B)
59267L107
Shares:175.0K
Value:$4.8M
% of Portfolio:0.2% ($4.8M/$2.8B)
002942100
Shares:500.0K
Value:$3.8M
% of Portfolio:0.1% ($3.8M/$2.8B)
008064107
Shares:1.4M
Value:$3.6M
% of Portfolio:0.1% ($3.6M/$2.8B)